Medical Care
Global Blood Product Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Mar 27, 25
- ID: 153335
- Pages: 107
- Figures: 101
- Views: 52
The global Blood Product market size was US$ 35330 million in 2024 and is forecast to a readjusted size of US$ 58200 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Blood Products are medical products derived from human blood and used for the treatment of various conditions. They include whole blood, blood components like red blood cells, platelets, and plasma, as well as plasma derivatives such as clotting factors and immunoglobulins. Blood products are essential in medical treatments, including surgeries, trauma care, and for patients with blood disorders, anemia, or immune deficiencies.
Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the Plasma Fractionation Technology market.
Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the Plasma Fractionation Technologyation market.
Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for Plasma Fractionation Technology to produce these therapies.
Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.
Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of Plasma Fractionation Technologyation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.
Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.
Stringent Regulatory Framework: Plasma Fractionation Technologyation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.
Complex Manufacturing Process: The Plasma Fractionation Technologyation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Plasma Fractionation Technology includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Fractionation Technology market.
North America is the largest consumption place, with a revenue market share nearly 40% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Fractionation Technology.
The global Blood Product market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
By Type: (Dominant Segment vs High-Margin Innovation)
Albumin
Immunoglobulin
Clotting Factor
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital
Retail Pharmacy
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Takeda in Europe)
- Emerging Product Trends: Albumin adoption vs. Immunoglobulin premiumization
- Demand-Side Dynamics: Hospital growth in China vs. Retail Pharmacy potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Blood Product market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Immunoglobulin in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Retail Pharmacy in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Blood Product value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Blood Products are medical products derived from human blood and used for the treatment of various conditions. They include whole blood, blood components like red blood cells, platelets, and plasma, as well as plasma derivatives such as clotting factors and immunoglobulins. Blood products are essential in medical treatments, including surgeries, trauma care, and for patients with blood disorders, anemia, or immune deficiencies.
Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the Plasma Fractionation Technology market.
Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the Plasma Fractionation Technologyation market.
Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for Plasma Fractionation Technology to produce these therapies.
Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.
Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of Plasma Fractionation Technologyation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.
Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.
Stringent Regulatory Framework: Plasma Fractionation Technologyation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.
Complex Manufacturing Process: The Plasma Fractionation Technologyation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Plasma Fractionation Technology includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Fractionation Technology market.
North America is the largest consumption place, with a revenue market share nearly 40% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Fractionation Technology.
The global Blood Product market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
By Type: (Dominant Segment vs High-Margin Innovation)
Albumin
Immunoglobulin
Clotting Factor
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital
Retail Pharmacy
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Takeda in Europe)
- Emerging Product Trends: Albumin adoption vs. Immunoglobulin premiumization
- Demand-Side Dynamics: Hospital growth in China vs. Retail Pharmacy potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Blood Product market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Immunoglobulin in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Retail Pharmacy in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Blood Product value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Clotting Factor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Product Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Blood Product Revenue Market Share by Region (2020-2025)
2.4 Global Blood Product Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Blood Product Market Size and Prospective (2020-2031)
2.5.2 Europe Blood Product Market Size and Prospective (2020-2031)
2.5.3 China Blood Product Market Size and Prospective (2020-2031)
2.5.4 Japan Blood Product Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Blood Product Historic Market Size by Type (2020-2025)
3.2 Global Blood Product Forecasted Market Size by Type (2026-2031)
3.3 Different Types Blood Product Representative Players
4 Breakdown Data by Application
4.1 Global Blood Product Historic Market Size by Application (2020-2025)
4.2 Global Blood Product Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Blood Product Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Blood Product Players by Revenue (2020-2025)
5.1.2 Global Blood Product Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Blood Product Revenue
5.4 Global Blood Product Market Concentration Analysis
5.4.1 Global Blood Product Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Blood Product Revenue in 2024
5.5 Global Key Players of Blood Product Head office and Area Served
5.6 Global Key Players of Blood Product, Product and Application
5.7 Global Key Players of Blood Product, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Blood Product Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Blood Product Market Size by Type (2020-2025)
6.1.2.2 North America Blood Product Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Blood Product Market Size by Application (2020-2025)
6.1.3.2 North America Blood Product Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Blood Product Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Blood Product Market Size by Type (2020-2025)
6.2.2.2 Europe Blood Product Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Blood Product Market Size by Application (2020-2025)
6.2.3.2 Europe Blood Product Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Blood Product Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Blood Product Market Size by Type (2020-2025)
6.3.2.2 China Blood Product Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Blood Product Market Size by Application (2020-2025)
6.3.3.2 China Blood Product Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Blood Product Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Blood Product Market Size by Type (2020-2025)
6.4.2.2 Japan Blood Product Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Blood Product Market Size by Application (2020-2025)
6.4.3.2 Japan Blood Product Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Takeda
7.1.1 Takeda Company Details
7.1.2 Takeda Business Overview
7.1.3 Takeda Blood Product Introduction
7.1.4 Takeda Revenue in Blood Product Business (2020-2025)
7.1.5 Takeda Recent Development
7.2 CSL
7.2.1 CSL Company Details
7.2.2 CSL Business Overview
7.2.3 CSL Blood Product Introduction
7.2.4 CSL Revenue in Blood Product Business (2020-2025)
7.2.5 CSL Recent Development
7.3 Grifols
7.3.1 Grifols Company Details
7.3.2 Grifols Business Overview
7.3.3 Grifols Blood Product Introduction
7.3.4 Grifols Revenue in Blood Product Business (2020-2025)
7.3.5 Grifols Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Details
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Blood Product Introduction
7.4.4 Octapharma Revenue in Blood Product Business (2020-2025)
7.4.5 Octapharma Recent Development
7.5 Kedrion
7.5.1 Kedrion Company Details
7.5.2 Kedrion Business Overview
7.5.3 Kedrion Blood Product Introduction
7.5.4 Kedrion Revenue in Blood Product Business (2020-2025)
7.5.5 Kedrion Recent Development
7.6 LFB Group
7.6.1 LFB Group Company Details
7.6.2 LFB Group Business Overview
7.6.3 LFB Group Blood Product Introduction
7.6.4 LFB Group Revenue in Blood Product Business (2020-2025)
7.6.5 LFB Group Recent Development
7.7 Biotest
7.7.1 Biotest Company Details
7.7.2 Biotest Business Overview
7.7.3 Biotest Blood Product Introduction
7.7.4 Biotest Revenue in Blood Product Business (2020-2025)
7.7.5 Biotest Recent Development
7.8 BPL
7.8.1 BPL Company Details
7.8.2 BPL Business Overview
7.8.3 BPL Blood Product Introduction
7.8.4 BPL Revenue in Blood Product Business (2020-2025)
7.8.5 BPL Recent Development
7.9 RAAS
7.9.1 RAAS Company Details
7.9.2 RAAS Business Overview
7.9.3 RAAS Blood Product Introduction
7.9.4 RAAS Revenue in Blood Product Business (2020-2025)
7.9.5 RAAS Recent Development
7.10 CBPO
7.10.1 CBPO Company Details
7.10.2 CBPO Business Overview
7.10.3 CBPO Blood Product Introduction
7.10.4 CBPO Revenue in Blood Product Business (2020-2025)
7.10.5 CBPO Recent Development
7.11 Hualan Bio
7.11.1 Hualan Bio Company Details
7.11.2 Hualan Bio Business Overview
7.11.3 Hualan Bio Blood Product Introduction
7.11.4 Hualan Bio Revenue in Blood Product Business (2020-2025)
7.11.5 Hualan Bio Recent Development
7.12 Tiantan Bio
7.12.1 Tiantan Bio Company Details
7.12.2 Tiantan Bio Business Overview
7.12.3 Tiantan Bio Blood Product Introduction
7.12.4 Tiantan Bio Revenue in Blood Product Business (2020-2025)
7.12.5 Tiantan Bio Recent Development
7.13 Shuanglin Bio
7.13.1 Shuanglin Bio Company Details
7.13.2 Shuanglin Bio Business Overview
7.13.3 Shuanglin Bio Blood Product Introduction
7.13.4 Shuanglin Bio Revenue in Blood Product Business (2020-2025)
7.13.5 Shuanglin Bio Recent Development
7.14 Boya Bio
7.14.1 Boya Bio Company Details
7.14.2 Boya Bio Business Overview
7.14.3 Boya Bio Blood Product Introduction
7.14.4 Boya Bio Revenue in Blood Product Business (2020-2025)
7.14.5 Boya Bio Recent Development
7.15 Yuanda Shuyang
7.15.1 Yuanda Shuyang Company Details
7.15.2 Yuanda Shuyang Business Overview
7.15.3 Yuanda Shuyang Blood Product Introduction
7.15.4 Yuanda Shuyang Revenue in Blood Product Business (2020-2025)
7.15.5 Yuanda Shuyang Recent Development
7.16 Weiguang Bio
7.16.1 Weiguang Bio Company Details
7.16.2 Weiguang Bio Business Overview
7.16.3 Weiguang Bio Blood Product Introduction
7.16.4 Weiguang Bio Revenue in Blood Product Business (2020-2025)
7.16.5 Weiguang Bio Recent Development
7.17 Nanyue Bio
7.17.1 Nanyue Bio Company Details
7.17.2 Nanyue Bio Business Overview
7.17.3 Nanyue Bio Blood Product Introduction
7.17.4 Nanyue Bio Revenue in Blood Product Business (2020-2025)
7.17.5 Nanyue Bio Recent Development
7.18 KM Biologics
7.18.1 KM Biologics Company Details
7.18.2 KM Biologics Business Overview
7.18.3 KM Biologics Blood Product Introduction
7.18.4 KM Biologics Revenue in Blood Product Business (2020-2025)
7.18.5 KM Biologics Recent Development
8 Blood Product Market Dynamics
8.1 Blood Product Industry Trends
8.2 Blood Product Market Drivers
8.3 Blood Product Market Challenges
8.4 Blood Product Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Clotting Factor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Product Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Blood Product Revenue Market Share by Region (2020-2025)
2.4 Global Blood Product Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Blood Product Market Size and Prospective (2020-2031)
2.5.2 Europe Blood Product Market Size and Prospective (2020-2031)
2.5.3 China Blood Product Market Size and Prospective (2020-2031)
2.5.4 Japan Blood Product Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Blood Product Historic Market Size by Type (2020-2025)
3.2 Global Blood Product Forecasted Market Size by Type (2026-2031)
3.3 Different Types Blood Product Representative Players
4 Breakdown Data by Application
4.1 Global Blood Product Historic Market Size by Application (2020-2025)
4.2 Global Blood Product Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Blood Product Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Blood Product Players by Revenue (2020-2025)
5.1.2 Global Blood Product Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Blood Product Revenue
5.4 Global Blood Product Market Concentration Analysis
5.4.1 Global Blood Product Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Blood Product Revenue in 2024
5.5 Global Key Players of Blood Product Head office and Area Served
5.6 Global Key Players of Blood Product, Product and Application
5.7 Global Key Players of Blood Product, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Blood Product Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Blood Product Market Size by Type (2020-2025)
6.1.2.2 North America Blood Product Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Blood Product Market Size by Application (2020-2025)
6.1.3.2 North America Blood Product Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Blood Product Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Blood Product Market Size by Type (2020-2025)
6.2.2.2 Europe Blood Product Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Blood Product Market Size by Application (2020-2025)
6.2.3.2 Europe Blood Product Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Blood Product Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Blood Product Market Size by Type (2020-2025)
6.3.2.2 China Blood Product Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Blood Product Market Size by Application (2020-2025)
6.3.3.2 China Blood Product Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Blood Product Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Blood Product Market Size by Type (2020-2025)
6.4.2.2 Japan Blood Product Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Blood Product Market Size by Application (2020-2025)
6.4.3.2 Japan Blood Product Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Takeda
7.1.1 Takeda Company Details
7.1.2 Takeda Business Overview
7.1.3 Takeda Blood Product Introduction
7.1.4 Takeda Revenue in Blood Product Business (2020-2025)
7.1.5 Takeda Recent Development
7.2 CSL
7.2.1 CSL Company Details
7.2.2 CSL Business Overview
7.2.3 CSL Blood Product Introduction
7.2.4 CSL Revenue in Blood Product Business (2020-2025)
7.2.5 CSL Recent Development
7.3 Grifols
7.3.1 Grifols Company Details
7.3.2 Grifols Business Overview
7.3.3 Grifols Blood Product Introduction
7.3.4 Grifols Revenue in Blood Product Business (2020-2025)
7.3.5 Grifols Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Details
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Blood Product Introduction
7.4.4 Octapharma Revenue in Blood Product Business (2020-2025)
7.4.5 Octapharma Recent Development
7.5 Kedrion
7.5.1 Kedrion Company Details
7.5.2 Kedrion Business Overview
7.5.3 Kedrion Blood Product Introduction
7.5.4 Kedrion Revenue in Blood Product Business (2020-2025)
7.5.5 Kedrion Recent Development
7.6 LFB Group
7.6.1 LFB Group Company Details
7.6.2 LFB Group Business Overview
7.6.3 LFB Group Blood Product Introduction
7.6.4 LFB Group Revenue in Blood Product Business (2020-2025)
7.6.5 LFB Group Recent Development
7.7 Biotest
7.7.1 Biotest Company Details
7.7.2 Biotest Business Overview
7.7.3 Biotest Blood Product Introduction
7.7.4 Biotest Revenue in Blood Product Business (2020-2025)
7.7.5 Biotest Recent Development
7.8 BPL
7.8.1 BPL Company Details
7.8.2 BPL Business Overview
7.8.3 BPL Blood Product Introduction
7.8.4 BPL Revenue in Blood Product Business (2020-2025)
7.8.5 BPL Recent Development
7.9 RAAS
7.9.1 RAAS Company Details
7.9.2 RAAS Business Overview
7.9.3 RAAS Blood Product Introduction
7.9.4 RAAS Revenue in Blood Product Business (2020-2025)
7.9.5 RAAS Recent Development
7.10 CBPO
7.10.1 CBPO Company Details
7.10.2 CBPO Business Overview
7.10.3 CBPO Blood Product Introduction
7.10.4 CBPO Revenue in Blood Product Business (2020-2025)
7.10.5 CBPO Recent Development
7.11 Hualan Bio
7.11.1 Hualan Bio Company Details
7.11.2 Hualan Bio Business Overview
7.11.3 Hualan Bio Blood Product Introduction
7.11.4 Hualan Bio Revenue in Blood Product Business (2020-2025)
7.11.5 Hualan Bio Recent Development
7.12 Tiantan Bio
7.12.1 Tiantan Bio Company Details
7.12.2 Tiantan Bio Business Overview
7.12.3 Tiantan Bio Blood Product Introduction
7.12.4 Tiantan Bio Revenue in Blood Product Business (2020-2025)
7.12.5 Tiantan Bio Recent Development
7.13 Shuanglin Bio
7.13.1 Shuanglin Bio Company Details
7.13.2 Shuanglin Bio Business Overview
7.13.3 Shuanglin Bio Blood Product Introduction
7.13.4 Shuanglin Bio Revenue in Blood Product Business (2020-2025)
7.13.5 Shuanglin Bio Recent Development
7.14 Boya Bio
7.14.1 Boya Bio Company Details
7.14.2 Boya Bio Business Overview
7.14.3 Boya Bio Blood Product Introduction
7.14.4 Boya Bio Revenue in Blood Product Business (2020-2025)
7.14.5 Boya Bio Recent Development
7.15 Yuanda Shuyang
7.15.1 Yuanda Shuyang Company Details
7.15.2 Yuanda Shuyang Business Overview
7.15.3 Yuanda Shuyang Blood Product Introduction
7.15.4 Yuanda Shuyang Revenue in Blood Product Business (2020-2025)
7.15.5 Yuanda Shuyang Recent Development
7.16 Weiguang Bio
7.16.1 Weiguang Bio Company Details
7.16.2 Weiguang Bio Business Overview
7.16.3 Weiguang Bio Blood Product Introduction
7.16.4 Weiguang Bio Revenue in Blood Product Business (2020-2025)
7.16.5 Weiguang Bio Recent Development
7.17 Nanyue Bio
7.17.1 Nanyue Bio Company Details
7.17.2 Nanyue Bio Business Overview
7.17.3 Nanyue Bio Blood Product Introduction
7.17.4 Nanyue Bio Revenue in Blood Product Business (2020-2025)
7.17.5 Nanyue Bio Recent Development
7.18 KM Biologics
7.18.1 KM Biologics Company Details
7.18.2 KM Biologics Business Overview
7.18.3 KM Biologics Blood Product Introduction
7.18.4 KM Biologics Revenue in Blood Product Business (2020-2025)
7.18.5 KM Biologics Recent Development
8 Blood Product Market Dynamics
8.1 Blood Product Industry Trends
8.2 Blood Product Market Drivers
8.3 Blood Product Market Challenges
8.4 Blood Product Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Blood Product Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Blood Product Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Blood Product Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Blood Product Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Blood Product Revenue Share by Region (2020-2025)
Table 6. Global Blood Product Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Blood Product Revenue Share Forecast by Region (2026-2031)
Table 8. Global Blood Product Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Blood Product Revenue Market Share by Type (2020-2025)
Table 10. Global Blood Product Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Blood Product Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Blood Product Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Blood Product Revenue Market Share by Application (2020-2025)
Table 15. Global Blood Product Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Blood Product Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Blood Product Application
Table 18. Global Blood Product Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Blood Product Market Share by Players (2020-2025)
Table 20. Global Top Blood Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Product as of 2024)
Table 21. Ranking of Global Top Blood Product Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Blood Product Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Blood Product, Headquarters and Area Served
Table 24. Global Key Players of Blood Product, Product and Application
Table 25. Global Key Players of Blood Product, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Blood Product Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Blood Product Revenue Market Share by Company (2020-2025)
Table 29. North America Blood Product Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Blood Product Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Blood Product Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Blood Product Revenue Market Share by Company (2020-2025)
Table 33. Europe Blood Product Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Blood Product Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Blood Product Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Blood Product Revenue Market Share by Company (2020-2025)
Table 37. China Blood Product Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Blood Product Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Blood Product Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Blood Product Revenue Market Share by Company (2020-2025)
Table 41. Japan Blood Product Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Blood Product Market Size by Application (2020-2025) & (US$ Million)
Table 43. Takeda Company Details
Table 44. Takeda Business Overview
Table 45. Takeda Blood Product Product
Table 46. Takeda Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 47. Takeda Recent Development
Table 48. CSL Company Details
Table 49. CSL Business Overview
Table 50. CSL Blood Product Product
Table 51. CSL Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 52. CSL Recent Development
Table 53. Grifols Company Details
Table 54. Grifols Business Overview
Table 55. Grifols Blood Product Product
Table 56. Grifols Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 57. Grifols Recent Development
Table 58. Octapharma Company Details
Table 59. Octapharma Business Overview
Table 60. Octapharma Blood Product Product
Table 61. Octapharma Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 62. Octapharma Recent Development
Table 63. Kedrion Company Details
Table 64. Kedrion Business Overview
Table 65. Kedrion Blood Product Product
Table 66. Kedrion Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 67. Kedrion Recent Development
Table 68. LFB Group Company Details
Table 69. LFB Group Business Overview
Table 70. LFB Group Blood Product Product
Table 71. LFB Group Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 72. LFB Group Recent Development
Table 73. Biotest Company Details
Table 74. Biotest Business Overview
Table 75. Biotest Blood Product Product
Table 76. Biotest Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 77. Biotest Recent Development
Table 78. BPL Company Details
Table 79. BPL Business Overview
Table 80. BPL Blood Product Product
Table 81. BPL Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 82. BPL Recent Development
Table 83. RAAS Company Details
Table 84. RAAS Business Overview
Table 85. RAAS Blood Product Product
Table 86. RAAS Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 87. RAAS Recent Development
Table 88. CBPO Company Details
Table 89. CBPO Business Overview
Table 90. CBPO Blood Product Product
Table 91. CBPO Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 92. CBPO Recent Development
Table 93. Hualan Bio Company Details
Table 94. Hualan Bio Business Overview
Table 95. Hualan Bio Blood Product Product
Table 96. Hualan Bio Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 97. Hualan Bio Recent Development
Table 98. Tiantan Bio Company Details
Table 99. Tiantan Bio Business Overview
Table 100. Tiantan Bio Blood Product Product
Table 101. Tiantan Bio Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 102. Tiantan Bio Recent Development
Table 103. Shuanglin Bio Company Details
Table 104. Shuanglin Bio Business Overview
Table 105. Shuanglin Bio Blood Product Product
Table 106. Shuanglin Bio Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 107. Shuanglin Bio Recent Development
Table 108. Boya Bio Company Details
Table 109. Boya Bio Business Overview
Table 110. Boya Bio Blood Product Product
Table 111. Boya Bio Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 112. Boya Bio Recent Development
Table 113. Yuanda Shuyang Company Details
Table 114. Yuanda Shuyang Business Overview
Table 115. Yuanda Shuyang Blood Product Product
Table 116. Yuanda Shuyang Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 117. Yuanda Shuyang Recent Development
Table 118. Weiguang Bio Company Details
Table 119. Weiguang Bio Business Overview
Table 120. Weiguang Bio Blood Product Product
Table 121. Weiguang Bio Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 122. Weiguang Bio Recent Development
Table 123. Nanyue Bio Company Details
Table 124. Nanyue Bio Business Overview
Table 125. Nanyue Bio Blood Product Product
Table 126. Nanyue Bio Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 127. Nanyue Bio Recent Development
Table 128. KM Biologics Company Details
Table 129. KM Biologics Business Overview
Table 130. KM Biologics Blood Product Product
Table 131. KM Biologics Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 132. KM Biologics Recent Development
Table 133. Blood Product Market Trends
Table 134. Blood Product Market Drivers
Table 135. Blood Product Market Challenges
Table 136. Blood Product Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood Product Product Picture
Figure 2. Global Blood Product Market Share by Type: 2024 VS 2031
Figure 3. Albumin Features
Figure 4. Immunoglobulin Features
Figure 5. Clotting Factor Features
Figure 6. Others Features
Figure 7. Global Blood Product Market Share by Application: 2024 VS 2031
Figure 8. Hospital
Figure 9. Retail Pharmacy
Figure 10. Other
Figure 11. Blood Product Report Years Considered
Figure 12. Global Blood Product Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Blood Product Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Blood Product Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Blood Product Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Blood Product Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Blood Product Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Blood Product Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Blood Product Market Share by Players in 2024
Figure 20. Global Top Blood Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Product as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Blood Product Revenue in 2024
Figure 22. North America Blood Product Market Share by Type (2020-2025)
Figure 23. North America Blood Product Market Share by Application (2020-2025)
Figure 24. Europe Blood Product Market Share by Type (2020-2025)
Figure 25. Europe Blood Product Market Share by Application (2020-2025)
Figure 26. China Blood Product Market Share by Type (2020-2025)
Figure 27. China Blood Product Market Share by Application (2020-2025)
Figure 28. Japan Blood Product Market Share by Type (2020-2025)
Figure 29. Japan Blood Product Market Share by Application (2020-2025)
Figure 30. Takeda Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 31. CSL Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 32. Grifols Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 33. Octapharma Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 34. Kedrion Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 35. LFB Group Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 36. Biotest Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 37. BPL Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 38. RAAS Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 39. CBPO Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 40. Hualan Bio Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 41. Tiantan Bio Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 42. Shuanglin Bio Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 43. Boya Bio Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 44. Yuanda Shuyang Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 45. Weiguang Bio Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 46. Nanyue Bio Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 47. KM Biologics Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Table 1. Global Blood Product Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Blood Product Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Blood Product Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Blood Product Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Blood Product Revenue Share by Region (2020-2025)
Table 6. Global Blood Product Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Blood Product Revenue Share Forecast by Region (2026-2031)
Table 8. Global Blood Product Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Blood Product Revenue Market Share by Type (2020-2025)
Table 10. Global Blood Product Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Blood Product Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Blood Product Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Blood Product Revenue Market Share by Application (2020-2025)
Table 15. Global Blood Product Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Blood Product Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Blood Product Application
Table 18. Global Blood Product Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Blood Product Market Share by Players (2020-2025)
Table 20. Global Top Blood Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Product as of 2024)
Table 21. Ranking of Global Top Blood Product Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Blood Product Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Blood Product, Headquarters and Area Served
Table 24. Global Key Players of Blood Product, Product and Application
Table 25. Global Key Players of Blood Product, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Blood Product Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Blood Product Revenue Market Share by Company (2020-2025)
Table 29. North America Blood Product Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Blood Product Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Blood Product Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Blood Product Revenue Market Share by Company (2020-2025)
Table 33. Europe Blood Product Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Blood Product Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Blood Product Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Blood Product Revenue Market Share by Company (2020-2025)
Table 37. China Blood Product Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Blood Product Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Blood Product Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Blood Product Revenue Market Share by Company (2020-2025)
Table 41. Japan Blood Product Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Blood Product Market Size by Application (2020-2025) & (US$ Million)
Table 43. Takeda Company Details
Table 44. Takeda Business Overview
Table 45. Takeda Blood Product Product
Table 46. Takeda Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 47. Takeda Recent Development
Table 48. CSL Company Details
Table 49. CSL Business Overview
Table 50. CSL Blood Product Product
Table 51. CSL Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 52. CSL Recent Development
Table 53. Grifols Company Details
Table 54. Grifols Business Overview
Table 55. Grifols Blood Product Product
Table 56. Grifols Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 57. Grifols Recent Development
Table 58. Octapharma Company Details
Table 59. Octapharma Business Overview
Table 60. Octapharma Blood Product Product
Table 61. Octapharma Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 62. Octapharma Recent Development
Table 63. Kedrion Company Details
Table 64. Kedrion Business Overview
Table 65. Kedrion Blood Product Product
Table 66. Kedrion Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 67. Kedrion Recent Development
Table 68. LFB Group Company Details
Table 69. LFB Group Business Overview
Table 70. LFB Group Blood Product Product
Table 71. LFB Group Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 72. LFB Group Recent Development
Table 73. Biotest Company Details
Table 74. Biotest Business Overview
Table 75. Biotest Blood Product Product
Table 76. Biotest Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 77. Biotest Recent Development
Table 78. BPL Company Details
Table 79. BPL Business Overview
Table 80. BPL Blood Product Product
Table 81. BPL Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 82. BPL Recent Development
Table 83. RAAS Company Details
Table 84. RAAS Business Overview
Table 85. RAAS Blood Product Product
Table 86. RAAS Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 87. RAAS Recent Development
Table 88. CBPO Company Details
Table 89. CBPO Business Overview
Table 90. CBPO Blood Product Product
Table 91. CBPO Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 92. CBPO Recent Development
Table 93. Hualan Bio Company Details
Table 94. Hualan Bio Business Overview
Table 95. Hualan Bio Blood Product Product
Table 96. Hualan Bio Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 97. Hualan Bio Recent Development
Table 98. Tiantan Bio Company Details
Table 99. Tiantan Bio Business Overview
Table 100. Tiantan Bio Blood Product Product
Table 101. Tiantan Bio Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 102. Tiantan Bio Recent Development
Table 103. Shuanglin Bio Company Details
Table 104. Shuanglin Bio Business Overview
Table 105. Shuanglin Bio Blood Product Product
Table 106. Shuanglin Bio Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 107. Shuanglin Bio Recent Development
Table 108. Boya Bio Company Details
Table 109. Boya Bio Business Overview
Table 110. Boya Bio Blood Product Product
Table 111. Boya Bio Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 112. Boya Bio Recent Development
Table 113. Yuanda Shuyang Company Details
Table 114. Yuanda Shuyang Business Overview
Table 115. Yuanda Shuyang Blood Product Product
Table 116. Yuanda Shuyang Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 117. Yuanda Shuyang Recent Development
Table 118. Weiguang Bio Company Details
Table 119. Weiguang Bio Business Overview
Table 120. Weiguang Bio Blood Product Product
Table 121. Weiguang Bio Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 122. Weiguang Bio Recent Development
Table 123. Nanyue Bio Company Details
Table 124. Nanyue Bio Business Overview
Table 125. Nanyue Bio Blood Product Product
Table 126. Nanyue Bio Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 127. Nanyue Bio Recent Development
Table 128. KM Biologics Company Details
Table 129. KM Biologics Business Overview
Table 130. KM Biologics Blood Product Product
Table 131. KM Biologics Revenue in Blood Product Business (2020-2025) & (US$ Million)
Table 132. KM Biologics Recent Development
Table 133. Blood Product Market Trends
Table 134. Blood Product Market Drivers
Table 135. Blood Product Market Challenges
Table 136. Blood Product Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood Product Product Picture
Figure 2. Global Blood Product Market Share by Type: 2024 VS 2031
Figure 3. Albumin Features
Figure 4. Immunoglobulin Features
Figure 5. Clotting Factor Features
Figure 6. Others Features
Figure 7. Global Blood Product Market Share by Application: 2024 VS 2031
Figure 8. Hospital
Figure 9. Retail Pharmacy
Figure 10. Other
Figure 11. Blood Product Report Years Considered
Figure 12. Global Blood Product Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Blood Product Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Blood Product Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Blood Product Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Blood Product Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Blood Product Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Blood Product Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Blood Product Market Share by Players in 2024
Figure 20. Global Top Blood Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Product as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Blood Product Revenue in 2024
Figure 22. North America Blood Product Market Share by Type (2020-2025)
Figure 23. North America Blood Product Market Share by Application (2020-2025)
Figure 24. Europe Blood Product Market Share by Type (2020-2025)
Figure 25. Europe Blood Product Market Share by Application (2020-2025)
Figure 26. China Blood Product Market Share by Type (2020-2025)
Figure 27. China Blood Product Market Share by Application (2020-2025)
Figure 28. Japan Blood Product Market Share by Type (2020-2025)
Figure 29. Japan Blood Product Market Share by Application (2020-2025)
Figure 30. Takeda Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 31. CSL Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 32. Grifols Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 33. Octapharma Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 34. Kedrion Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 35. LFB Group Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 36. Biotest Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 37. BPL Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 38. RAAS Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 39. CBPO Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 40. Hualan Bio Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 41. Tiantan Bio Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 42. Shuanglin Bio Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 43. Boya Bio Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 44. Yuanda Shuyang Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 45. Weiguang Bio Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 46. Nanyue Bio Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 47. KM Biologics Revenue Growth Rate in Blood Product Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232